Survival of veterans treated with enzalutamide and abiraterone in advanced prostate cancer.

被引：0
|
作者：
Schoen, Martin W.
Carson, Kenneth Robert
Luo, Suhong
Eisen, Seth
Reimers, Melissa Andrea
Drake, Bettina F.
Bennett, Charles L.
Knoche, Eric Marshall
Yan, Yan
Sanfilippo, Kristen Marie
机构：
[1] St Louis Univ, Sch Med, St Louis, MO USA
[2] St Louis Vet Affairs Med Ctr, Res Serv, St Louis, MO USA
[3] St Louis Vet Affairs Med Ctr, St Louis, MO USA
[4] Washington Univ, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Med, Div Med Oncol, St Louis, MO 63110 USA
[6] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA
[7] South Carolina Coll Pharm, Columbia, SC USA
[8] Washington Univ, Sch Med, Div Med Oncol, St Louis, MO USA
[9] Washington Univ, Barnes & Jewish Hosp, St Louis, MO 63110 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.5032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5032
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Hospitalizations Among Veterans Treated for Metastatic Prostate Cancer With Abiraterone or Enzalutamide
    Riekhof, Forest
    Yan, Yan
    Bennett, Charles L.
    Sanfilippo, Kristen M.
    Carson, Kenneth R.
    Chang, Su-Hsin
    Georgantopoulos, Peter
    Luo, Suhong
    Govindan, Srinivas
    Cheranda, Nina
    Afzal, Amber
    Schoen, Martin W.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 18 - 26.e3
  • [2] Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancer
    Deol, Ekamjit S.
    Sanfilippo, Kristen M.
    Luo, Suhong
    Fiala, Mark A.
    Wildes, Tanya
    Mian, Hira
    Schoen, Martin W.
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (05)
  • [3] Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases
    Martin W. Schoen
    Kenneth R. Carson
    Seth A. Eisen
    Charles L. Bennett
    Suhong Luo
    Melissa A. Reimers
    Eric M. Knoche
    Alison L. Whitmer
    Yan Yan
    Bettina F. Drake
    Kristen M. Sanfilippo
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 811 - 811
  • [4] Circulating tumour cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.
    De laere, Brain
    Van Oyen, Peter
    Ghysel, Christophe
    Ost, Piet
    Demey, Wim
    Hoekx, Lucien
    Schrijvers, Dirk L.
    Brouwers, Barbara Anna Henk
    Lybaert, Willem
    Everaert, Els Grieta
    Ampe, Jozef
    Van Kerckhove, Piet
    De Maeseneer, Daan Joost
    Strijbos, Michiel Hendrik
    Bols, Alain
    Fransis, Karen
    Van den Eynden, Gert
    Vandebroek, Jean
    Van Laere, Steven J.
    Dirix, Luc Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Overall survival between veterans with metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone with kidney disease.
    Wilson, Robert
    Doherty, Jason M.
    Luo, Suhong
    Candelieri-Surette, Danielle
    Eaton Jr, Daniel B.
    Schoen, Martin W.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [6] Current Understanding of Resistance to Abiraterone and Enzalutamide in Advanced Prostate Cancer
    Antonarakis, Emmanuel S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (05) : 316 - 319
  • [7] Effect of BMI and hemoglobin A1c on survival of veterans with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide
    Govindan, Srinivas
    Cheranda, Nina
    Riekhof, Forest
    Luo, Suhong
    Schoen, Martin W.
    PROSTATE, 2024, 84 (03): : 245 - 253
  • [8] A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide
    Leuva, Harshraj
    Sigel, Keith
    Zhou, Mengxi
    Wilkerson, Julia
    Aggen, David H.
    Park, Yeun-Hee Anna
    Anderson, Christopher B.
    Hsu, Ta-Chueh Melody
    Langhoff, Erik
    McWilliams, Glen
    Drake, Charles G.
    Simon, Richard
    Bates, Susan E.
    Fojo, Tito
    SEMINARS IN ONCOLOGY, 2019, 46 (4-5) : 351 - 361
  • [9] Characteristics and comorbidities of veterans treated with enzalutamide or abiraterone.
    Patel, Mukti
    Riekhof, Forest
    Sanfilippo, Kristen Marie
    Carson, Kenneth Robert
    Schoen, Martin W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Duration of Treatment in Prostate Cancer Patients Treated with Abiraterone Acetate or Enzalutamide
    Pilon, Dominic
    Behl, Ajay S.
    Ellis, Lorie A.
    Emond, Bruno
    Lefebvre, Patrick
    Dawson, Nancy A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (02): : 225 - 225
12345